Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.
Najjar M, Suebsuwong C, Ray SS, Thapa RJ, Maki JL, Nogusa S, Shah S, Saleh D, Gough PJ, Bertin J, Yuan J, Balachandran S, Cuny GD, Degterev A.
Najjar M, et al. Among authors: ray ss.
Cell Rep. 2015 Mar 24;10(11):1850-60. doi: 10.1016/j.celrep.2015.02.052.
Cell Rep. 2015.
PMID: 25801024
Free PMC article.